loadpatents
name:-0.015598058700562
name:-0.0075719356536865
name:-0.0062057971954346
Swaroop; Anand Patent Filings

Swaroop; Anand

Patent Applications and Registrations

Patent applications and USPTO patent grants for Swaroop; Anand.The latest application filed is for "combination of a novel topical gel and oral supplements for healing diabetic foot and other wounds".

Company Profile
5.7.14
  • Swaroop; Anand - Bethesda MD
  • Swaroop; Anand - Belle Mead NJ
  • Swaroop; Anand - Gaithersburg MD
  • Swaroop; Anand - Ann Arbor MI US
  • Swaroop; Anand - Himachal Pradesh IN
  • Swaroop; Anand - Palampur IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and compositions for treating Leber congenital amaurosis
Grant 11,421,219 - Wu , et al. August 23, 2
2022-08-23
Combination Of A Novel Topical Gel And Oral Supplements For Healing Diabetic Foot And Other Wounds
App 20210106646 - Pandey; Ramendra N. ;   et al.
2021-04-15
Rp2 And Rpgr Vectors For Treating X-linked Retinitis Pigmentosa
App 20200289670 - Wu; Zhijian ;   et al.
2020-09-17
RP2 and RPGR vectors for treating X-linked retinitis pigmentosa
Grant 10,646,588 - Wu , et al.
2020-05-12
Methods And Compositions For Treating Leber Congenital Amaurosis
App 20200024593 - WU; Zhijian ;   et al.
2020-01-23
Methods and compositions for treating leber congenital amaurosis
Grant 10,351,844 - Wu , et al. July 16, 2
2019-07-16
Rp2 And Rpgr Vectors For Treating X-linked Retinitis Pigmentosa
App 20180043035 - Wu; Zhijian ;   et al.
2018-02-15
Methods And Compositions For Treating Leber Congenital Amaurosis
App 20170275615 - WU; Zhijian ;   et al.
2017-09-28
Compositions And Methods For Diagnosing And Treating Macular Degeneration
App 20130266937 - Swaroop; Anand ;   et al.
2013-10-10
Compositions And Methods For Diagnosing And Treating Macular Degeneration
App 20120135884 - Swaroop; Anand ;   et al.
2012-05-31
Compositions and methods for diagnosing and treating macular degeneration
Grant 8,119,348 - Swaroop , et al. February 21, 2
2012-02-21
Compositions And Methods For Diagnosing And Treating Macular Degeneration
App 20110014716 - Swaroop; Anand ;   et al.
2011-01-20
NPH6 nucleic acids and proteins
Grant 7,838,231 - Hidebrandt , et al. November 23, 2
2010-11-23
Single step green process for the preparation of substituted cinnamic esters with trans-selectivity
Grant 7,741,508 - Sinha , et al. June 22, 2
2010-06-22
Photoreceptor Precursor Cells
App 20100136537 - Swaroop; Anand ;   et al.
2010-06-03
Compositions And Methods For Diagnosing And Treating Macular Degeneration
App 20090203001 - Swaroop; Anand ;   et al.
2009-08-13
NPHP nucleic acids and proteins
Grant 7,517,648 - Hildebrandt , et al. April 14, 2
2009-04-14
Single step green process for the preparation of substituted cinnamic esters with trans-selectivity
App 20080045742 - Sinha; Arun Kumar ;   et al.
2008-02-21
NPH6 nucleic acids and proteins
App 20080044831 - Hidebrandt; Friedhelm ;   et al.
2008-02-21
NPHP nucleic acids and proteins
App 20050214864 - Hildebrandt, Friedhelm ;   et al.
2005-09-29
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed